About Danaher
Danaher is a publicly listed company based in Washington (United States) founded in 1969, and was acquired by Screenverse in June 2021. Dental equipment and medical instruments are manufactured for therapeutic areas. The company has 63,000 employees. Danaher has completed 46 acquisitions, including AVT, Abcam and Aldevron. Its chief executive, as recorded, is Rainer Blair. Its website danaher.com draws about 276 thousand monthly visits. Danaher offers products and services including Biotechnology Services, Diagnostics Tools, and Life Sciences Technologies. Its focus areas include Diversified Medical Devices and Devices. Its legal entity is Danaher Corporation. Its competitors include GE Healthcare, Medtronic and Boston Scientific; 1 of its 3 listed competitors has raised funding.
Company details
RD company focused on manufacturing dental equipment for multiple therapeutic areas. Its other products include medical consumables, water quality analysis instruments, life science research instruments, and diagnostic tools. In 2021, the company recorded annual revenues of 22.28B and a net profit of 3.64B. In 2022, the company recorded annual revenues of 31.47B and a net profit of 7.2B.
- Headquarters Washington, United States
- Employees 63,000
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website danaher.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Screenverse (Jun 2021)
- Legal Name Danaher Corporation
- Annual Revenue$24.57 B (USD)2.9as on Dec 31, 2025
- Net Profit$3.61 B (USD)-7.31as on Dec 31, 2025
- EBITDA$7.7 B (USD)2.16as on Dec 31, 2025
- Latest Funding Round$12.91M (USD), Post-IPO
Apr 2018
- InvestorsBank of America
& 1 more
- Employee Count63,000
- Investments & AcquisitionsAVT
& 45 more
- Acquired byScreenverse
(Jun 2021)
Products & Services of Danaher
Danaher offers a comprehensive portfolio of products and services, including Biotechnology Services, Diagnostics Tools, and Life Sciences Technologies.
Accelerates development and commercialization of innovative therapies
Provides tools for precise and rapid health diagnoses
Supports innovations in cell therapies and fluid filtration
Apps and channels of Danaher
its YouTube channel Danaher Corporation has 3.78K subscribers and 30 videos.
Videos from Danaher
The most watched videos on Danaher's YouTube channel, Danaher Corporation (3.78K subscribers). Click a video to play it here.
More on Danaher Corporation.
Funding Insights of Danaher
- Total Rounds 4
- Last Round Post-IPO — $12.91M
- First Round $450M
(Jan 2001)
- Investors Count 1
All 4 funding rounds of Danaher with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | $12.91M | Post-IPO | – | – | – |
| Mar 2018 | $1B | Debt – Conventional | – | – | |
| Sep 2015 | $2B | Debt – Conventional | – | – | – |
| Jan 2001 | $450M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in Danaher
Danaher has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Bank of America and Screenverse.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Commercial banking and asset management services are offered worldwide. | 1904 | bankofamerica.com | Charlotte, United States | |
Provider of advertising services | 2020 | screenversemedia.com | New York, United States |
Investor details for Danaher
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Danaher
778 people are tracked at Danaher (386 in leadership, 20 in board & advisors, 372 in team); the tracked headcount is 63,000.
| Name | Role | Group |
|---|---|---|
Rainer Blair | CEO | Leadership |
Deepu Joseph | Director Talent Acquisition, Sea, Hong Kong & Taiwan | Leadership |
Rosina Palmer | Director Of Strategic Development | Leadership |
Maria Lopez | Vice President, Human Resources, Product Identification Platform | Leadership |
Hannah Kohrs | General Manager Development Program (gmdp) | Leadership |
Amit Agrawal | Chief Scientific Officer, Diagnostics Platform | Leadership |
Hiroyasu Suzuki | Director, DBS Office Lean | Leadership |
Carrie Uhl | Chief Procurement Officer | Leadership |
Paulo Goffi | Latin America & Caribbean HR & EHS Director | Leadership |
Diane Hartwick | Vice President Human Resources, Latin America | Leadership |
Chelsea Creech | General Manager Development Program (gmdp) | Leadership |
Matt Hicks | Director, Talent Acquisition | Leadership |
Scott Levin | Vice President, Clinical Science & Evidence Generation At Danaher Diagnostics | Leadership |
David Pratt | DBSO Director, Lean | Leadership |
Sofia Piquero Monge | Senior Talent Acquisition Partner South Europe | Leadership |
Craig S. | Vice President, HR Operations & Insights | Leadership |
An Yee Angelina Cho | General Manager Development Program | Leadership |
Rikke Flindt Bergstedt | Vice President, Danaher Human Resources Europe | Leadership |
Matt McGrew | EVP, CFO | Leadership |
Laura Butler | Sr. Director, Executive Talent Planning | Leadership |
758 more people are available in the full profile.
Complete people profiles for Danaher
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Danaher
Danaher is a publicly listed company on the NYSE with ticker symbol DHR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Dec 2023
- Listed onEuronext: 1DHR
- Listed entityDanaher Corporation
- Exchange sectorHealth technology
- ISINUS2358511028
- Share price$222.84 (+0.74% on the day) · 2026-10-13
- Market capitalisation$156.65B
- Price to earnings39.6
- EPS (diluted, trailing year)$5.63
- Dividend yield0.68%
- Volume (last session)6,007,547
Financials of Danaher
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $24.57B | $3.61B | $7.70B |
| 2024 | $23.88B | $3.90B | $7.54B |
| 2023 | $23.89B | $4.76B | $7.45B |
| 2022 | $26.64B | $7.21B | $9.67B |
| 2021 | $29.45B | $6.43B | $10.22B |
Detailed financial statements for Danaher
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Danaher
Danaher has strategically engaged in corporate development activities, having acquired 46 companies. Notable acquisitions include AVT, Abcam and Aldevron.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of wide range of devices to monitor health parameters | masimo.com | Irvine, United States | 1989 | Feb 2026 | $9.9B | |
Software solutions are developed for drug discovery and life sciences. | genedata.com | Basel, Switzerland | 1997 | Aug 2024 | •••• | |
Biological reagents and antibodies are developed for life science research. | abcam.com | Cambridge, United Kingdom | 1998 | Aug 2023 | $5.7B | |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | aldevron.com | Fargo, United States | 1998 | Jun 2021 | $9.6B | |
Instruments, kits, and reagents for nanomedicine development are manufactured. | precisionnanosystems.com | Vancouver, Canada | 2010 | Jun 2021 | •••• | |
Materials management solutions are provided for healthcare organizations. | gehealthcare.com | Chicago, United States | 1892 | Apr 2020 | $21.4B | |
Provider of oligonucleotide-based reagents and kits | idtdna.com | Coralville, United States | 1987 | Mar 2018 | •••• | |
Data management is provided for research teams' screening experiments. | idbs.com | Guildford, United Kingdom | 1989 | Oct 2017 | •••• | |
AVT is recognized for providing advanced print inspection solutions. | avt-inc.com | Israel | 1992 | Feb 2017 | $100M | |
Analytical chemistry solutions for separation and purification applications | phenomenex.com | Torrance, United States | 1982 | Oct 2016 | •••• |
Complete acquisition details for Danaher
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Danaher
15 dated milestones of Danaher across 57 years, from founding to its latest funding, stage changes and deals.
- Founded Danaher is founded.
- Funding First funding round of $450.0M.
- Acquisition Acquires Phenomenex.
- Acquisition Acquires AVT.
- Acquisition Acquires IDBS.
- Acquisition Acquires Integrated DNA Technologies.
- Funding Latest funding round, Post-IPO, of $12.9M.
- Acquisition Acquires GE Healthcare.
- Acquisition Acquires Precision Nanosystems.
- Acquisition Acquires Aldevron.
- Exit Acquired by Screenverse.
- Acquisition Acquires Abcam.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Genedata.
- Acquisition Acquires Masimo.
Competitors of Danaher
Danaher has 3 listed competitors in our database, 1 of them funded. They include GE Healthcare, Medtronic and Boston Scientific.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gehealthcare.com | 1892 | Chicago, United States | $29.13M | 16,700 | Materials management solutions are provided for healthcare organizations. | |
| medtronic.com | 1949 | Minneapolis, United States | 1,114 | Medical equipment for treating over 30 chronic diseases is developed. | ||
| bostonscientific.com | 1979 | Marlborough, United States | 63,359 | Wide range of medical devices |
Detailed competitors of Danaher
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Danaher
The website of Danaher (danaher.com) receives about 276.4K visits a month.
- Monthly visits276.4K
▲ 20.3% vs previous month
Websites whose visitors overlap most with Danaher. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
paycomonline.net | paycomonline.net | 100% | #1,997 | – | |
| idt.net | 86% | 97.7K | #468,540 | View details | |
uafc.com | uafc.com | 66% | – | ||
| centene.com | 66% | 757.5K | #63,618 | View details | |
| chase.com | 57% | 198.6M | #125 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Danaher
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Danaher (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Danaher
Complete news archive for Danaher
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Danaher
Danaher was founded in 1969 and raised its 1st funding round 32 years after it was founded.
Danaher is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Rainer Blair is the CEO of Danaher, as recorded in our data.
Danaher has 63,000 employees.
Annual revenue of Danaher is $24.57B as on Dec 31, 2025.
RD company focused on manufacturing dental equipment for multiple therapeutic areas. Its other products include medical consumables, water quality analysis instruments, life science research instruments, and diagnostic tools. In 2021, the company recorded annual revenues of 22.28B and a net profit of 3.64B. In 2022, the company recorded annual revenues of 31.47B and a net profit of 7.2B.
Danaher's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Danaher offers Biotechnology Services, Diagnostics Tools, and Life Sciences Technologies.
Yes, Danaher is publicly traded on NYSE under the ticker symbol DHR.
Danaher has 2 investors. Key investors include Bank of America, and Screenverse.
Danaher operates through Danaher Corporation.